<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39524912</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Overlapping conditions in Long COVID at a multisite academic center.</ArticleTitle><Pagination><StartPage>1482917</StartPage><MedlinePgn>1482917</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1482917</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2024.1482917</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Many patients experience persistent symptoms after COVID-19, a syndrome referred to as Long COVID (LC). The goal of this study was to identify novel new or worsening comorbidities self-reported in patients with LC.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients diagnosed with LC (<i>n</i>&#x2009;=&#x2009;732) at the Mayo Long COVID Care Clinic in Rochester, Minnesota and Jacksonville, Florida were sent questionnaires to assess the development of new or worsening comorbidities following COVID-19 compared to patients with SARS-CoV-2 that did not develop LC (controls). Both groups were also asked questions screening for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), generalized joint hypermobility (GJH) and orthostatic intolerance. 247 people with LC (33.7%) and 40 controls (50%) responded to the surveys.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In this study LC patients averaged 53&#x2009;years of age and were predominantly White (95%) women (75%). The greatest prevalence of new or worsening comorbidities following SARS-CoV-2 infection in patients with LC vs. controls reported in this study were pain (94.4% vs. 0%, <i>p</i>&#x2009;&lt;&#x2009;0.001), neurological (92.4% vs. 15.4%, <i>p</i>&#x2009;&lt;&#x2009;0.001), sleep (82.8% vs. 5.3%, <i>p</i>&#x2009;&lt;&#x2009;0.001), skin (69.8% vs. 0%, <i>p</i>&#x2009;&lt;&#x2009;0.001), and genitourinary (60.6% vs. 25.0%, <i>p</i>&#x2009;=&#x2009;0.029) issues. 58% of LC patients screened positive for ME/CFS vs. 0% of controls (<i>p</i>&#x2009;&lt;&#x2009;0.001), 27% positive for GJH compared to 10% of controls (<i>p</i>&#x2009;=&#x2009;0.026), and a positive average score of 4.0 on orthostatic intolerance vs. 0 (<i>p</i>&#x2009;&lt;&#x2009;0.001). The majority of LC patients with ME/CFS were women (77%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We found that comorbidities across 12 surveyed categories were increased in patients following SARS-CoV-2 infection. Our data also support the overlap of LC with ME/CFS, GJH, and orthostatic intolerance. We discuss the pathophysiologic, research, and clinical implications of identifying these conditions with LC.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Grach, Dudenkov, Pollack, Fairweather, Aakre, Munipalli, Croghan, Mueller, Overgaard, Bruno, Collins, Li, Hurt, Tal, Ganesh and Knight.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Grach</LastName><ForeName>Stephanie L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dudenkov</LastName><ForeName>Daniel V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pollack</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fairweather</LastName><ForeName>DeLisa</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aakre</LastName><ForeName>Chris A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munipalli</LastName><ForeName>Bala</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croghan</LastName><ForeName>Ivana T</ForeName><Initials>IT</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Quantitative Health Sciences, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overgaard</LastName><ForeName>Joshua D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruno</LastName><ForeName>Katelyn A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, University of Florida, Gainesville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Nerissa M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurt</LastName><ForeName>Ryan T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tal</LastName><ForeName>Michal C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Stem Cell Biology &amp; Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesh</LastName><ForeName>Ravindra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Dacre T R</ForeName><Initials>DTR</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">generalized joint hypermobility</Keyword><Keyword MajorTopicYN="N">hypermobile Ehlers-Danlos syndrome</Keyword><Keyword MajorTopicYN="N">mast cells</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">orthostatic intolerance</Keyword><Keyword MajorTopicYN="N">pain</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>RTH is a consultant for Nestle Nutrition. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>11</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39524912</ArticleId><ArticleId IdType="pmc">PMC11543549</ArticleId><ArticleId IdType="doi">10.3389/fneur.2024.1482917</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. . Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. (2021) 8:100186. doi: 10.1016/j.lanepe.2021.100186, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. . Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. (2021) 4:e210830. doi: 10.1001/jamanetworkopen.2021.0830, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>(ASPA) ASfPA . Terms &amp; definitions. COVID.gov (2023). Available at: https://www.covid.gov/be-informed/longcovid/about (Accessed August 18, 2024).</Citation></Reference><Reference><Citation>National Academies of Sciences E, Medicine In: Fineberg HV, Brown L, Worku T, Goldowitz I, editors. A long COVID definition: a chronic, systemic disease state with profound consequences. Washington, DC: The National Academies Press; (2024). 186.</Citation><ArticleIdList><ArticleId IdType="pubmed">39110819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bureau NCfHSUSC . Household pulse survey, 2022&#x2013;2024. Long COVID. Available at: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (Accessed August 18, 2024).</Citation></Reference><Reference><Citation>Mirin AA. A preliminary estimate of the economic impact of long COVID in the United States. Fatigue: Biomed, Health Behav. (2022) 10:190&#x2013;9. doi: 10.1080/21641846.2022.2124064</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2022.2124064</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Grach SL, Ghosh AK, Bierle DM, Salonen BR, Collins NM, et al. . The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin Proc. (2022) 97:454&#x2013;64. doi: 10.1016/j.mayocp.2021.11.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med. (2022) 4:90. doi: 10.1007/s42399-022-01167-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01167-4</ArticleId><ArticleId IdType="pmc">PMC8977184</ArticleId><ArticleId IdType="pubmed">35402784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, et al. . Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med. (2023) 29:226&#x2013;35. doi: 10.1038/s41591-022-02116-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. doi: 10.1038/s41591-021-01292-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester SV, Rusu R, Chan B, Bellows M, O'Keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin. (2022) 38:1391&#x2013;9. doi: 10.1080/03007995.2022.2081454, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurt RT, Yadav S, Schroeder DR, Croghan IT, Mueller MR, Grach SL, et al. . Longitudinal progression of patients with long COVID treated in a post-COVID clinic: a cross-sectional survey. J Prim Care Community Health. (2024) 15:21501319241258671. doi: 10.1177/21501319241258671, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319241258671</ArticleId><ArticleId IdType="pmc">PMC11141226</ArticleId><ArticleId IdType="pubmed">38813984</ArticleId></ArticleIdList></Reference><Reference><Citation>Grut V, Bistr&#xf6;m M, Salzer J, Stridh P, Jons D, Gustafsson R, et al. . Interactions between high seroreactivity to human herpes virus 6A and Epstein-Barr virus in MS development: a presymptomatic case-control study. Ann Neurol. (2024) 96:302&#x2013;5. doi: 10.1002/ana.27009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.27009</ArticleId><ArticleId IdType="pubmed">38860471</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. (2019) 11:1&#x2013;18. doi: 10.3390/v11080762, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Azadeh N, Limper AH, Carmona EM, Ryu JH. The role of infection in interstitial lung diseases: a review. Chest. (2017) 152:842&#x2013;52. doi: 10.1016/j.chest.2017.03.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2017.03.033</ArticleId><ArticleId IdType="pmc">PMC7094545</ArticleId><ArticleId IdType="pubmed">28400116</ArticleId></ArticleIdList></Reference><Reference><Citation>Vesco KK, Whitlock EP, Eder M, Lin J, Burda BU, Senger CA, et al. . U.S. preventive services task force evidence syntheses, formerly systematic evidence reviews. Screening for cervical cancer: a systematic evidence review for the US preventive services task force. Rockville (MD): Agency for Healthcare Research and Quality (US) (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22132428</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochim Biophys Acta. (2009) 1792:714&#x2013;21. doi: 10.1016/j.bbadis.2008.08.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2008.08.001</ArticleId><ArticleId IdType="pmc">PMC4642437</ArticleId><ArticleId IdType="pubmed">18760350</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns DM, Itzhaki RF, Kaplan DL. Potential involvement of varicella zoster virus in Alzheimer's disease via reactivation of quiescent herpes simplex virus type 1. J Alzheimers Dis. (2022) 88:1189&#x2013;200. doi: 10.3233/JAD-220287, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220287</ArticleId><ArticleId IdType="pubmed">35754275</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipil&#xe4; PN, Heikkil&#xe4; N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M, et al. . Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis. (2021) 21:1557&#x2013;67. doi: 10.1016/S1473-3099(21)00144-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00144-4</ArticleId><ArticleId IdType="pmc">PMC8592915</ArticleId><ArticleId IdType="pubmed">34166620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. (2006) 333:575. doi: 10.1136/bmj.38933.585764.AE, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron B, Flamand L, Juwana H, Middeldorp J, Naing Z, Rawlinson W, et al. . Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. J Med Virol. (2010) 82:1684&#x2013;8. doi: 10.1002/jmv.21873, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21873</ArticleId><ArticleId IdType="pubmed">20827765</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiner P, Harrer T, Scheibenbogen C, Lamer S, Schlosser A, Naviaux RK, et al. . Human Herpesvirus-6 reactivation, mitochondrial fragmentation, and the coordination of antiviral and metabolic phenotypes in Myalgic encephalomyelitis/chronic fatigue syndrome. Immunohorizons. (2020) 4:201&#x2013;15. doi: 10.4049/immunohorizons.2000006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2000006</ArticleId><ArticleId IdType="pubmed">32327453</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. . Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2018) 16:268. doi: 10.1186/s12967-018-1644-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolou E, Ros&#xe9;n A. Epigenetic reprograming in myalgic encephalomyelitis/chronic fatigue syndrome: a narrative of latent viruses. J Intern Med. (2024) 296:93&#x2013;115. doi: 10.1111/joim.13792, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13792</ArticleId><ArticleId IdType="pubmed">38693641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Quach TC, Tiwari A, Bonilla AE, Miglis M, Yang PC, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. (2023) 14:1090747. doi: 10.3389/fneur.2023.1090747, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Legler F, Meyer-Arndt L, M&#xf6;dl L, Kedor C, Freitag H, Stein E, et al. . Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort. EClinicalMedicine. (2023) 63:102146. doi: 10.1016/j.eclinm.2023.102146, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102146</ArticleId><ArticleId IdType="pmc">PMC10469383</ArticleId><ArticleId IdType="pubmed">37662515</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Dorri JA. ME/CFS and post-exertional malaise among patients with long COVID. Neurol Int. (2022) 15:1&#x2013;11. doi: 10.3390/neurolint15010001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15010001</ArticleId><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley MC, Gallagher C, Ong E, Langdon A, Chieng J, Bailey D, et al. . High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long COVID: implications for management and health care planning. Am J Med. (2023). doi: 10.1016/j.amjmed.2023.06.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.06.010</ArticleId><ArticleId IdType="pmc">PMC10307671</ArticleId><ArticleId IdType="pubmed">37391116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaffi J, Vanni E, Mancarella L, Brusi V, Lisi L, Pignatti F, et al. . Post-acute COVID-19 joint pain and new onset of rheumatic musculoskeletal diseases: a systematic review. Diagnostics (Basel). (2023) 63:259&#x2013;262. doi: 10.3390/diagnostics13111850</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13111850</ArticleId><ArticleId IdType="pmc">PMC10252492</ArticleId><ArticleId IdType="pubmed">37296705</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Rowe PC, Visser FC. Low sensitivity of abbreviated tilt table testing for diagnosing postural tachycardia syndrome in adults with ME/CFS. Front Pediatr. (2018) 6:349. doi: 10.3389/fped.2018.00349, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00349</ArticleId><ArticleId IdType="pmc">PMC6250822</ArticleId><ArticleId IdType="pubmed">30505831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Morales R, Berm&#xfa;dez-Ben&#xed;tez E, Mart&#xed;nez-Mart&#xed;nez LA, Mart&#xed;nez-Lav&#xed;n M. Clinical overlap between fibromyalgia and myalgic encephalomyelitis. A systematic review and meta-analysis. Autoimmun Rev. (2022) 21:103129. doi: 10.1016/j.autrev.2022.103129, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103129</ArticleId><ArticleId IdType="pubmed">35690247</ArticleId></ArticleIdList></Reference><Reference><Citation>Brock I, Chopra P, Maitland A, Francomano C. eP305 - frequency and co-occurrence of comorbidities in the Ehlers-Danlos syndromes. Mol Genet Metab. (2021) 132:S194. doi: 10.1016/S1096-7192(21)00387-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1096-7192(21)00387-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AJ, Stiles LE, Sheehan T, Bascom R, Levy HP, Francomano CA, et al. . Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome. Auton Neurosci. (2020) 224:102637. doi: 10.1016/j.autneu.2020.102637, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2020.102637</ArticleId><ArticleId IdType="pmc">PMC7282488</ArticleId><ArticleId IdType="pubmed">31954224</ArticleId></ArticleIdList></Reference><Reference><Citation>Brag&#xe9;e B, Michos A, Drum B, Fahlgren M, Szulkin R, Bertilson BC. Signs of intracranial hypertension, hypermobility, and craniocervical obstructions in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. (2020) 11:828. doi: 10.3389/fneur.2020.00828, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00828</ArticleId><ArticleId IdType="pmc">PMC7485557</ArticleId><ArticleId IdType="pubmed">32982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudie K, Ramiller A, Whittaker S, Phillips LE. Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data. Front Neurol. (2024) 15:1324879. doi: 10.3389/fneur.2024.1324879, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2024.1324879</ArticleId><ArticleId IdType="pmc">PMC10965591</ArticleId><ArticleId IdType="pubmed">38545281</ArticleId></ArticleIdList></Reference><Reference><Citation>Logarbo BP, Yang M, Longo MT, Kingry C, Courseault J. Long COVID and the diagnosis of underlying hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. PM R. (2023) 16:935&#x2013;7. doi: 10.1002/pmrj.13120</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.13120</ArticleId><ArticleId IdType="pubmed">38116712</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. (2021) 27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Bruno KA, Darakjian AA, Bruce BK, Gehin JM, Kotha A, et al. . High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Front Med (Lausanne). (2023) 10:1096180. doi: 10.3389/fmed.2023.1096180, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1096180</ArticleId><ArticleId IdType="pmc">PMC10166812</ArticleId><ArticleId IdType="pubmed">37181352</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight DRT, Bruno KA, Singh A, Munipalli B, Gajarawala S, Solomon M, et al. . Cardiac defects of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study. Front Cardiovasc Med. (2024) 11:1332508. doi: 10.3389/fcvm.2024.1332508, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2024.1332508</ArticleId><ArticleId IdType="pmc">PMC10982405</ArticleId><ArticleId IdType="pubmed">38562189</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue S, Board on the Health of Select P, Institute of M . The National Academies Collection: reports funded by National Institutes of Health. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: Redefining an illness. Washington (DC): National Academies Press (US) (2015).</Citation></Reference><Reference><Citation>Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract. (2003) 57:163&#x2013;6. doi: 10.1111/j.1742-1241.2003.tb10455.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2003.tb10455.x</ArticleId><ArticleId IdType="pubmed">12723715</ArticleId></ArticleIdList></Reference><Reference><Citation>Glans MR, Thelin N, Humble MB, Elwin M, Bejerot S. The relationship between generalised joint hypermobility and autism Spectrum disorder in adults: a large, cross-sectional, case control comparison. Front Psychiatry. (2021) 12:803334. doi: 10.3389/fpsyt.2021.803334</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.803334</ArticleId><ArticleId IdType="pmc">PMC8861852</ArticleId><ArticleId IdType="pubmed">35211037</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. . The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. (2017) 175:8&#x2013;26. doi: 10.1002/ajmg.c.31552</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31552</ArticleId><ArticleId IdType="pubmed">28306229</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. (2012) 87:1196&#x2013;201. doi: 10.1016/j.mayocp.2012.10.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Eccles JA, Dorina C, Quadt L, Hakim AJ, Gall N, Bowyer V, et al. . Is joint hypermobility linked to self-reported non-recovery from COVID-19? Case control evidence from the British COVID symptom study biobank. BMJ Public Health. (2024) 2:e000478. doi: 10.1136/bmjph-2023-000478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjph-2023-000478</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. . Symptoms, complications and management of long COVID: a review. J R Soc Med. (2021) 114:428&#x2013;42. doi: 10.1177/01410768211032850, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavrilova N, Soprun L, Lukashenko M, Ryabkova V, Fedotkina TV, Churilov LP, et al. . New clinical phenotype of the post-Covid syndrome: fibromyalgia and joint hypermobility condition. Pathophysiology. (2022) 29:24&#x2013;9. doi: 10.3390/pathophysiology29010003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology29010003</ArticleId><ArticleId IdType="pmc">PMC8954589</ArticleId><ArticleId IdType="pubmed">35366287</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvache-Mateo A, Navas-Otero A, Heredia-Ciur&#xf3; A, Mat&#xed;n-N&#xfa;&#xf1;ez J, Torres-S&#xe1;nchez I, L&#xf3;pez-L&#xf3;pez L, et al. . Post-COVID patients with new-onset chronic pain 2 years after infection: cross-sectional study. Pain Manag Nurs. (2023) 24:528&#x2013;34. doi: 10.1016/j.pmn.2023.04.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmn.2023.04.010</ArticleId><ArticleId IdType="pmc">PMC10201348</ArticleId><ArticleId IdType="pubmed">37225540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabir MF, Yin KN, Jeffree MS, Ahmedy FB, Zainudin MF, Htwe O, et al. . Clinical presentation of post-COVID pain and its impact on quality of life in long COVID patients: a cross-sectional household survey of SARS-CoV-2 cases in Bangladesh. BMC Infect Dis. (2024) 24:375. doi: 10.1186/s12879-024-09267-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09267-3</ArticleId><ArticleId IdType="pmc">PMC10993502</ArticleId><ArticleId IdType="pubmed">38575878</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmans RS, Clauw DJ, Flint C, Harris H, Lederman S, Schrepf A. Chronic overlapping pain conditions increase the risk of long COVID features, regardless of acute COVID status. Pain. (2024) 165:1112&#x2013;20. doi: 10.1097/j.pain.0000000000003110, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000003110</ArticleId><ArticleId IdType="pmc">PMC11017744</ArticleId><ArticleId IdType="pubmed">38112577</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards CC, 3rd, Edwards CC, 2nd, Heinlein S, Rowe PC. Case report: recurrent cervical spinal stenosis masquerading as myalgic encephalomyelitis/chronic fatigue syndrome with orthostatic intolerance. Front Neurol. (2023) 14:1284062. doi: 10.3389/fneur.2023.1284062, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1284062</ArticleId><ArticleId IdType="pmc">PMC10720627</ArticleId><ArticleId IdType="pubmed">38099073</ArticleId></ArticleIdList></Reference><Reference><Citation>Holman AJ. Positional cervical spinal cord compression and fibromyalgia: a novel comorbidity with important diagnostic and treatment implications. J Pain. (2008) 9:613&#x2013;22. doi: 10.1016/j.jpain.2008.01.339, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2008.01.339</ArticleId><ArticleId IdType="pubmed">18499527</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffez DS, Ross RE, Shade-Zeldow Y, Kostas K, Shah S, Gottschalk R, et al. . Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia. Eur Spine J. (2004) 13:516&#x2013;23. doi: 10.1007/s00586-004-0672-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-004-0672-x</ArticleId><ArticleId IdType="pmc">PMC3476600</ArticleId><ArticleId IdType="pubmed">15083352</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson FC, Sr, Rosenbaum R, Narayanan M, Koby M, Tuchman K, Rowe PC, et al. . Atlanto-axial rotary instability (fielding type 1): characteristic clinical and radiological findings, and treatment outcomes following alignment, fusion, and stabilization. Neurosurg Rev. (2021) 44:1553&#x2013;68. doi: 10.1007/s10143-020-01345-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10143-020-01345-9</ArticleId><ArticleId IdType="pmc">PMC8121728</ArticleId><ArticleId IdType="pubmed">32623537</ArticleId></ArticleIdList></Reference><Reference><Citation>Midtlien JP, Curry BP, Chang E, Kiritsis NR, Aldridge JB, Fargen KM. Characterizing a new clinical phenotype: the co-existence of cerebral venous outflow and connective tissue disorders. Front Neurol. (2023) 14:1305972. doi: 10.3389/fneur.2023.1305972</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1305972</ArticleId><ArticleId IdType="pmc">PMC10806170</ArticleId><ArticleId IdType="pubmed">38269002</ArticleId></ArticleIdList></Reference><Reference><Citation>Eccles JA, Thompson B, Themelis K, Amato ML, Stocks R, Pound A, et al. . Beyond bones: the relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational study. Clin Med (Lond). (2021) 21:53&#x2013;8. doi: 10.7861/clinmed.2020-0743, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0743</ArticleId><ArticleId IdType="pmc">PMC7850199</ArticleId><ArticleId IdType="pubmed">33479068</ArticleId></ArticleIdList></Reference><Reference><Citation>Roma M, Marden CL, De Wandele I, Francomano CA, Rowe PC. Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome. Auton Neurosci. (2018) 215:89&#x2013;96. doi: 10.1016/j.autneu.2018.02.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.02.006</ArticleId><ArticleId IdType="pubmed">29519641</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med. (2003) 115:33&#x2013;40. doi: 10.1016/S0002-9343(03)00235-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(03)00235-3</ArticleId><ArticleId IdType="pubmed">12867232</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wandele I, Calders P, Peersman W, Rimbaut S, De Backer T, Malfait F, et al. . Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls. Semin Arthritis Rheum. (2014) 44:353&#x2013;61. doi: 10.1016/j.semarthrit.2014.05.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2014.05.013</ArticleId><ArticleId IdType="pubmed">24968706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallman D, Weinberg J, Hohler AD. Ehlers-Danlos syndrome and postural tachycardia syndrome: a relationship study. J Neurol Sci. (2014) 340:99&#x2013;102. doi: 10.1016/j.jns.2014.03.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.03.002</ArticleId><ArticleId IdType="pubmed">24685354</ArticleId></ArticleIdList></Reference><Reference><Citation>Celletti C, Borsellino B, Castori M, Censi F, Calcagnini G, Camerota F, et al. . A new insight on postural tachycardia syndrome in 102 adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder. Monaldi Arch Chest Dis. (2020) 90:259&#x2013;262. doi: 10.4081/monaldi.2020.1286, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2020.1286</ArticleId><ArticleId IdType="pubmed">32434316</ArticleId></ArticleIdList></Reference><Reference><Citation>Fermo OP. Evaluation and management of orthostatic headache in hypermobility disorders. Front Neurol. (2023) 14:1321350. doi: 10.3389/fneur.2023.1321350, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1321350</ArticleId><ArticleId IdType="pmc">PMC10755912</ArticleId><ArticleId IdType="pubmed">38162438</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeza-Velasco C. Neurodevelopmental atypisms in the context of joint hypermobility, hypermobility spectrum disorders, and Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. (2021) 187:491&#x2013;9. doi: 10.1002/ajmg.c.31946, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31946</ArticleId><ArticleId IdType="pubmed">34741402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindgren E, Qui&#xf1;ones Perez A, Knez R. Prevalence of ADHD and autism spectrum disorder in children with hypermobility spectrum disorders or hypermobile Ehlers-Danlos syndrome: a retrospective study. Neuropsychiatr Dis Treat. (2021) 17:379&#x2013;88. doi: 10.2147/NDT.S290494, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S290494</ArticleId><ArticleId IdType="pmc">PMC7882457</ArticleId><ArticleId IdType="pubmed">33603376</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Funk S, Bateman L, Stoddard GJ, Hammer S, Sullivan K, et al. . Orthostatic challenge causes distinctive symptomatic, hemodynamic and cognitive responses in long COVID and Myalgic encephalomyelitis/chronic fatigue syndrome. Front Med (Lausanne). (2022) 9:917019. doi: 10.3389/fmed.2022.917019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.917019</ArticleId><ArticleId IdType="pmc">PMC9285104</ArticleId><ArticleId IdType="pubmed">35847821</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen C, Visser FC. Long-haul COVID patients: prevalence of POTS are reduced but cerebral blood flow abnormalities remain abnormal with longer disease duration. Healthcare (Basel). (2022) 10:1&#x2013;9. doi: 10.3390/healthcare10102105</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10102105</ArticleId><ArticleId IdType="pmc">PMC9602558</ArticleId><ArticleId IdType="pubmed">36292552</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena-Orbea C, Lapin B, Li Y, Englund K, Heinzinger C, Foldvary-Schaefer N, et al. . Sleep disturbance severity and correlates in post-acute sequelae of COVID-19 (PASC). J Gen Intern Med. (2023) 38:2015&#x2013;7. doi: 10.1007/s11606-023-08187-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-023-08187-3</ArticleId><ArticleId IdType="pmc">PMC10072019</ArticleId><ArticleId IdType="pubmed">37014604</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowakowski S, Kokonda M, Sultana R, Duong BB, Nagy SE, Zaidan MF, et al. . Association between sleep quality and mental health among patients at a post-COVID-19 recovery clinic. Brain Sci. (2022) 12:1&#x2013;11. doi: 10.3390/brainsci12050586, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12050586</ArticleId><ArticleId IdType="pmc">PMC9139253</ArticleId><ArticleId IdType="pubmed">35624973</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien C, Heine J, Khalil A, Schlenker L, Hartung TJ, Boesl F, et al. . Altered brain perfusion and oxygen levels relate to sleepiness and attention in post-COVID syndrome. Ann Clin Transl Neurol. (2024) 11:2016&#x2013;29. doi: 10.1002/acn3.52121, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.52121</ArticleId><ArticleId IdType="pmc">PMC11330224</ArticleId><ArticleId IdType="pubmed">38874398</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferr&#xe9; A. Chronic fatigue syndrome and sleep disorders: clinical associations and diagnostic difficulties. Neurologia (Engl Ed). (2016) doi: 10.1016/j.nrl.2015.11.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2015.11.019</ArticleId><ArticleId IdType="pubmed">26877195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, H&#xe4;user W, Katz RL, et al. . 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. (2016) 46:319&#x2013;29. doi: 10.1016/j.semarthrit.2016.08.012, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2016.08.012</ArticleId><ArticleId IdType="pubmed">27916278</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbraecken J, Declerck A, Van de Heyning P, De Backer W, Wouters EF. Evaluation for sleep apnea in patients with Ehlers-Danlos syndrome and Marfan: a questionnaire study. Clin Genet. (2001) 60:360&#x2013;5. doi: 10.1034/j.1399-0004.2001.600507.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-0004.2001.600507.x</ArticleId><ArticleId IdType="pubmed">11903337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ic&#x103; OM, Mitroi G, Iano&#x15f;i SL, Tutunaru CV, Leru PM, Matei D, et al. . Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic. Romanian J Morphol Embryol. (2023) 64:291&#x2013;304. doi: 10.47162/RJME.64.3.01, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.47162/RJME.64.3.01</ArticleId><ArticleId IdType="pmc">PMC10720941</ArticleId><ArticleId IdType="pubmed">37867347</ArticleId></ArticleIdList></Reference><Reference><Citation>Edimo CO, Wajsberg JR, Wong S, Nahmias ZP, Riley BA. The dermatological aspects of hEDS in women. Int J Womens Dermatol. (2021) 7:285&#x2013;9. doi: 10.1016/j.ijwd.2021.01.020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijwd.2021.01.020</ArticleId><ArticleId IdType="pmc">PMC8243129</ArticleId><ArticleId IdType="pubmed">34222585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihele DM, Nistor PA, Bruma G, Mitran CI, Mitran MI, Condrat CE, et al. . Mast cell activation syndrome update-a dermatological perspective. J Pers Med. (2023) 13:1&#x2013;21. doi: 10.3390/jpm13071116, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm13071116</ArticleId><ArticleId IdType="pmc">PMC10381535</ArticleId><ArticleId IdType="pubmed">37511729</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack B, von Saltza E, McCorkell L, Santos L, Hultman A, Cohen AK, et al. . Female reproductive health impacts of long COVID and associated illnesses including ME/CFS, POTS, and connective tissue disorders: a literature review. Front Rehabil Sci. (2023) 4:1122673. doi: 10.3389/fresc.2023.1122673, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fresc.2023.1122673</ArticleId><ArticleId IdType="pmc">PMC10208411</ArticleId><ArticleId IdType="pubmed">37234076</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh LJ, Mallett VT, Frahm JD, Richardson DA, Evans MI. Gynecologic disorders in women with Ehlers-Danlos syndrome. J Soc Gynecol Investig. (1995) 2:559&#x2013;64. doi: 10.1177/107155769500200309, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/107155769500200309</ArticleId><ArticleId IdType="pubmed">9420859</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Anand A, Adderley NJ, Okoth K, Toulis KA, Gokhale K, et al. . Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur J Endocrinol. (2021) 184:637&#x2013;45. doi: 10.1530/EJE-20-1163, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-1163</ArticleId><ArticleId IdType="pmc">PMC8052516</ArticleId><ArticleId IdType="pubmed">33635829</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H-J, Appelman B, Willemen H, Bos A, Prado J, Geyer CE, et al. . Transfer of IgG from long COVID patients induces symptomology in mice. bioRxiv. (2024) doi: 10.1101/2024.05.30.596590</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.05.30.596590</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Rhermoul FZ, Fedorowski A, Eardley P, Taraborrelli P, Panagopoulos D, Sutton R, et al. . Autoimmunity in long Covid and POTS. Oxf Open Immunol. (2023) 4:1&#x2013;9. doi: 10.1093/oxfimm/iqad002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqad002</ArticleId><ArticleId IdType="pmc">PMC10224806</ArticleId><ArticleId IdType="pubmed">37255928</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos Guedes de Sa K, Silva J, Bayarri-Olmos R, Brinda R, Alec Rath Constable R, Colom Diaz PA, et al. . A causal link between autoantibodies and neurological symptoms in long COVID. medRxiv. (2024) doi: 10.1101/2024.06.18.24309100</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.06.18.24309100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SH, Ju HJ, Han JH, Lee JH, Lee WS, Bae JM, et al. . Autoimmune and autoinflammatory connective tissue disorders following COVID-19. JAMA Netw Open. (2023) 6:e2336120. doi: 10.1001/jamanetworkopen.2023.36120, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.36120</ArticleId><ArticleId IdType="pmc">PMC10559181</ArticleId><ArticleId IdType="pubmed">37801317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, Lee H, Lee SW, Kwon R, Rhee SY, Lee JA, et al. . Long-term autoimmune inflammatory rheumatic outcomes of COVID-19: a binational cohort study. Ann Intern Med. (2024) 177:291&#x2013;302. doi: 10.7326/M23-1831, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M23-1831</ArticleId><ArticleId IdType="pubmed">38437702</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndr. (2003) 11:7&#x2013;115. doi: 10.1300/J092v11n01_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. . Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. doi: 10.1111/j.1365-2796.2011.02428.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Van Herck M, Deng Q, Delbressine JM, Jason LA, Spruit MA. Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort. J Transl Med. (2023) 21:112. doi: 10.1186/s12967-023-03946-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03946-6</ArticleId><ArticleId IdType="pmc">PMC9921324</ArticleId><ArticleId IdType="pubmed">36765375</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer RF, Dempsey TT, Afrin LB. Chemical intolerance and mast cell activation: a suspicious synchronicity. J Xenobiot. (2023) 13:704&#x2013;18. doi: 10.3390/jox13040045, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jox13040045</ArticleId><ArticleId IdType="pmc">PMC10660865</ArticleId><ArticleId IdType="pubmed">37987446</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in long-COVID. Int J Infect Dis. (2021) 112:217&#x2013;26. doi: 10.1016/j.ijid.2021.09.043, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. (2020) 100:327&#x2013;32. doi: 10.1016/j.ijid.2020.09.016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Clues to long COVID. Science. (2022) 376:1261&#x2013;5. doi: 10.1126/science.add4297, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E. Myalgic encephalomyelitis/chronic fatigue syndrome: the biology of a neglected disease. Front Immunol. (2024) 15:1386607. doi: 10.3389/fimmu.2024.1386607, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1386607</ArticleId><ArticleId IdType="pmc">PMC11180809</ArticleId><ArticleId IdType="pubmed">38887284</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough E, Inigo J, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, et al. . Mitochondrial dynamics in SARS-COV2 spike protein treated human microglia: implications for neuro-COVID. J Neuroimmune Pharmacol. (2021) 16:770&#x2013;84. doi: 10.1007/s11481-021-10015-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10015-6</ArticleId><ArticleId IdType="pmc">PMC8487226</ArticleId><ArticleId IdType="pubmed">34599743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Hanson M. In: NINDS, editor. Report of the ME/CFS research roadmap working group of council (2024) Available at: https://www.ninds.nih.gov/about-ninds/who-we-are/advisory-council/nandsc-mecfs-research-roadmap-working-group</Citation></Reference><Reference><Citation>Castori M, Camerota F, Celletti C, Grammatico P, Padua L. Ehlers-Danlos syndrome hypermobility type and the excess of affected females: possible mechanisms and perspectives. Am J Med Genet A. (2010) 152A:2406&#x2013;8. doi: 10.1002/ajmg.a.33585</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.33585</ArticleId><ArticleId IdType="pubmed">20684008</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfait F, De Paepe A. The Ehlers-Danlos syndrome. Adv Exp Med Biol. (2014) 802:129&#x2013;43. doi: 10.1007/978-94-007-7893-1_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-94-007-7893-1_9</ArticleId><ArticleId IdType="pubmed">24443025</ArticleId></ArticleIdList></Reference><Reference><Citation>Grach SL, Seltzer J, Chon TY, Ganesh R. Diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome. Mayo Clin Proc. (2023) 98:1544&#x2013;51. doi: 10.1016/j.mayocp.2023.07.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2023.07.032</ArticleId><ArticleId IdType="pubmed">37793728</ArticleId></ArticleIdList></Reference><Reference><Citation>Boris JR, Shadiack EC, 3rd, McCormick EM, MacMullen L, George-Sankoh I, Falk MJ. Long-term POTS outcomes survey: diagnosis, therapy, and clinical outcomes. J Am Heart Assoc. (2024) 13:e033485. doi: 10.1161/JAHA.123.033485, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.123.033485</ArticleId><ArticleId IdType="pmc">PMC11292765</ArticleId><ArticleId IdType="pubmed">38958137</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J, Takahashi T, Wood J, Lu P, Tabachnikova A, Gehlhausen JR, et al. . Sex differences in symptomatology and immune profiles of long COVID. medRxiv. (2024) doi: 10.1101/2024.02.29.24303568</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.02.29.24303568</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn SE, Perry WA, Klein SL. Mechanisms and consequences of sex differences in immune responses. Nat Rev Nephrol. (2024) 20:37&#x2013;55. doi: 10.1038/s41581-023-00787-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-023-00787-w</ArticleId><ArticleId IdType="pubmed">37993681</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. (2001) 2:777&#x2013;80. doi: 10.1038/ni0901-777</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni0901-777</ArticleId><ArticleId IdType="pubmed">11526384</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno KA, Morales-Lara AC, Bittencourt EB, Siddiqui H, Bommarito G, Patel J, et al. . Sex differences in comorbidities associated with Sj&#xf6;gren's disease. Front Med (Lausanne) (2022) 9:958670. doi: 10.3389/fmed.2022.958670, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.958670</ArticleId><ArticleId IdType="pmc">PMC9387724</ArticleId><ArticleId IdType="pubmed">35991633</ArticleId></ArticleIdList></Reference><Reference><Citation>Calissendorff J, Cramon PK, Hallengren B, Khamisi S, Lantz M, Planck T, et al. . Long-term outcome of Graves' disease: a gender perspective. Womens Health Rep (New Rochelle). (2023) 4:487&#x2013;96. doi: 10.1089/whr.2023.0073, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/whr.2023.0073</ArticleId><ArticleId IdType="pmc">PMC10561747</ArticleId><ArticleId IdType="pubmed">37818181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes M, Pauling JD, Armstrong-James L, Denton CP, Galdas P, Flurey C. Gender-related differences in systemic sclerosis. Autoimmun Rev. (2020) 19:102494. doi: 10.1016/j.autrev.2020.102494, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102494</ArticleId><ArticleId IdType="pubmed">32062031</ArticleId></ArticleIdList></Reference><Reference><Citation>Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. (2006) 15:308&#x2013;18. doi: 10.1191/0961203306lu2305xx, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203306lu2305xx</ArticleId><ArticleId IdType="pubmed">16761508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaresan B, Shirafkan F, Ripperger K, Rattay K. The role of viral infections in the onset of autoimmune diseases. Viruses. (2023) 15:1&#x2013;32. doi: 10.3390/v15030782, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030782</ArticleId><ArticleId IdType="pmc">PMC10051805</ArticleId><ArticleId IdType="pubmed">36992490</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor MP, Kirkegaard K. Modification of cellular autophagy protein LC3 by poliovirus. J Virol. (2007) 81:12543&#x2013;53. doi: 10.1128/JVI.00755-07, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00755-07</ArticleId><ArticleId IdType="pmc">PMC2169029</ArticleId><ArticleId IdType="pubmed">17804493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyei GB, Dinkins C, Davis AS, Roberts E, Singh SB, Dong C, et al. . Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol. (2009) 186:255&#x2013;68. doi: 10.1083/jcb.200903070, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200903070</ArticleId><ArticleId IdType="pmc">PMC2717652</ArticleId><ArticleId IdType="pubmed">19635843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gannag&#xe9; M, Dormann D, Albrecht R, Dengjel J, Torossi T, R&#xe4;mer PC, et al. . Matrix protein 2 of influenza a virus blocks autophagosome fusion with lysosomes. Cell Host Microbe. (2009) 6:367&#x2013;80. doi: 10.1016/j.chom.2009.09.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.09.005</ArticleId><ArticleId IdType="pmc">PMC2774833</ArticleId><ArticleId IdType="pubmed">19837376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SJ, Syed GH, Khan M, Chiu WW, Sohail MA, Gish RG, et al. . Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc Natl Acad Sci USA. (2014) 111:6413&#x2013;8. doi: 10.1073/pnas.1321114111, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1321114111</ArticleId><ArticleId IdType="pmc">PMC4035934</ArticleId><ArticleId IdType="pubmed">24733894</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin J, McIntyre L, Stotland A, Feuer R, Gottlieb RA. Coxsackievirus B escapes the infected cell in ejected mitophagosomes. J Virol. (2017) 91:e01347&#x2013;17. doi: 10.1128/JVI.01347-17, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-17</ArticleId><ArticleId IdType="pmc">PMC5709598</ArticleId><ArticleId IdType="pubmed">28978702</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SJ, Lim BK, Yun J, Shin OS. CVB3-mediated mitophagy plays an important role in viral replication via abrogation of interferon pathways. Front Cell Infect Microbiol. (2021) 11:704494. doi: 10.3389/fcimb.2021.704494, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.704494</ArticleId><ArticleId IdType="pmc">PMC8292102</ArticleId><ArticleId IdType="pubmed">34295842</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wu Y, Meng X, Wang Z, Younis M, Liu Y, et al. . SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK. Cell Death Differ. (2022) 29:1395&#x2013;408. doi: 10.1038/s41418-022-00928-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-00928-x</ArticleId><ArticleId IdType="pmc">PMC8752586</ArticleId><ArticleId IdType="pubmed">35022571</ArticleId></ArticleIdList></Reference><Reference><Citation>Faizan MI, Chaudhuri R, Sagar S, Albogami S, Chaudhary N, Azmi I, et al. . NSP4 and ORF9b of SARS-CoV-2 induce pro-inflammatory mitochondrial DNA release in inner membrane-derived vesicles. Cells. (2022) 11:1&#x2013;36. doi: 10.3390/cells11192969, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11192969</ArticleId><ArticleId IdType="pmc">PMC9561960</ArticleId><ArticleId IdType="pubmed">36230930</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Florio DN, Beetler DJ, McCabe EJ, Sin J, Ikezu T, Fairweather D. Mitochondrial extracellular vesicles, autoimmunity and myocarditis. Front Immunol. (2024) 15:1374796. doi: 10.3389/fimmu.2024.1374796, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1374796</ArticleId><ArticleId IdType="pmc">PMC10972887</ArticleId><ArticleId IdType="pubmed">38550582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Rev Cardiol. (2023) 20:281&#x2013;2. doi: 10.1038/s41569-023-00842-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Csecs JLL, Iodice V, Rae CL, Brooke A, Simmons R, Quadt L, et al. . Joint hypermobility links neurodivergence to dysautonomia and pain. Front Psych. (2021) 12:786916. doi: 10.3389/fpsyt.2021.786916</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.786916</ArticleId><ArticleId IdType="pmc">PMC8847158</ArticleId><ArticleId IdType="pubmed">35185636</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan ZY, Barnden LR, Kwiatek RA, Bhuta S, Hermens DF, Lagopoulos J. Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. J Transl Med. (2020) 18:335. doi: 10.1186/s12967-020-02506-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02506-6</ArticleId><ArticleId IdType="pmc">PMC7466519</ArticleId><ArticleId IdType="pubmed">32873297</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapaliya K, Marshall-Gradisnik S, Eaton-Fitch N, Eftekhari Z, Inderyas M, Barnden L. Imbalanced brain neurochemicals in long COVID and ME/CFS: a preliminary study using MRI. Am J Med. (2024). doi: 10.1016/j.amjmed.2024.04.007, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2024.04.007</ArticleId><ArticleId IdType="pubmed">38588934</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. . Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study. J Nucl Med. (2014) 55:945&#x2013;50. doi: 10.2967/jnumed.113.131045, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.113.131045</ArticleId><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz T, Dudouet P, Campion JY, Kaphan E, Radulesco T, Gonzalez S, et al. . Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [(18)F]FDG-PET study. Eur J Nucl Med Mol Imaging. (2024) 51:3215&#x2013;22. doi: 10.1007/s00259-024-06775-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-024-06775-x</ArticleId><ArticleId IdType="pubmed">38862619</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudman L, De Smedt A, Roggeman S, Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Hatem SM, Schiltz M, et al. . Association between experimental pain measurements and the central sensitization inventory in patients at least 3 months after COVID-19 infection: a cross-sectional pilot study. J Clin Med. (2023) 12:1&#x2013;14. doi: 10.3390/jcm12020661, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020661</ArticleId><ArticleId IdType="pmc">PMC9862134</ArticleId><ArticleId IdType="pubmed">36675590</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R, Shunmugam L, Naidoo K, Abdool Karim SS, Wilkins D, Garzino-Demo A, et al. . Long COVID: a review and proposed visualization of the complexity of long COVID. Front Immunol. (2023) 14:1117464. doi: 10.3389/fimmu.2023.1117464, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1117464</ArticleId><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun S, Storan A, Myers B. Mast cell activation syndrome and the link with long COVID. Br J Hosp Med (Lond). (2022) 83:1&#x2013;10. doi: 10.12968/hmed.2022.0123, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/hmed.2022.0123</ArticleId><ArticleId IdType="pubmed">35938771</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC. Potential association of mast cells with coronavirus disease 2019. Ann Allergy Asthma Immunol. (2021) 126:217&#x2013;8. doi: 10.1016/j.anai.2020.11.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7644430</ArticleId><ArticleId IdType="pubmed">33161155</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Beetler DJ, Di Florio DN, Musigk N, Heidecker B, Cooper LT, Jr. COVID-19, myocarditis and pericarditis. Circ Res. (2023) 132:1302&#x2013;19. doi: 10.1161/CIRCRESAHA.123.321878, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.123.321878</ArticleId><ArticleId IdType="pmc">PMC10171304</ArticleId><ArticleId IdType="pubmed">37167363</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Tsilioni I, Ren H. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders? Expert Rev Clin Immunol. (2019) 15:639&#x2013;56. doi: 10.1080/1744666X.2019.1596800, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2019.1596800</ArticleId><ArticleId IdType="pmc">PMC7003574</ArticleId><ArticleId IdType="pubmed">30884251</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoshima S, Okayama Y. Neuro-allergology: mast cell-nerve cross-talk. Allergol Int. (2022) 71:288&#x2013;93. doi: 10.1016/j.alit.2022.04.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2022.04.002</ArticleId><ArticleId IdType="pubmed">35688775</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F, Liu X, Ou H, Li X, Liu R, Lv X, et al. . The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2. MBio. (2024) 15:e01088&#x2013;24. doi: 10.1128/mbio.01088-24</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.01088-24</ArticleId><ArticleId IdType="pmc">PMC11324024</ArticleId><ArticleId IdType="pubmed">38953634</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, et al. . Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol. (2004) 165:1883&#x2013;94. doi: 10.1016/S0002-9440(10)63241-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63241-5</ArticleId><ArticleId IdType="pmc">PMC1618717</ArticleId><ArticleId IdType="pubmed">15579433</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P, Caraffa A, Tet&#xe8; G, Gallenga CE, Ross R, Kritas SK, et al. . Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. J Biol Regul Homeost Agents. (2020) 34:1629&#x2013;32. doi: 10.23812/20-2EDIT, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-2EDIT</ArticleId><ArticleId IdType="pubmed">32945158</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P, Ronconi G, Lauritano D, Mastrangelo F, Caraffa A, Gallenga CE, et al. . Impact of TNF and IL-33 cytokines on mast cells in neuroinflammation. Int J Mol Sci. (2024) 25:1&#x2013;16. doi: 10.3390/ijms25063248, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25063248</ArticleId><ArticleId IdType="pmc">PMC10969930</ArticleId><ArticleId IdType="pubmed">38542222</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Yadav S, Hurt RT, Mueller MR, Aakre CA, Gilman EA, et al. . Pro inflammatory cytokines profiles of patients with long COVID differ between variant epochs. J Prim Care Community Health. (2024) 15:21501319241254751. doi: 10.1177/21501319241254751, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319241254751</ArticleId><ArticleId IdType="pmc">PMC11138192</ArticleId><ArticleId IdType="pubmed">38808863</ArticleId></ArticleIdList></Reference><Reference><Citation>Abston ED, Coronado MJ, Bucek A, Bedja D, Shin J, Kim JB, et al. . Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin Dev Immunol. (2012) 2012:129486. doi: 10.1155/2012/129486</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/129486</ArticleId><ArticleId IdType="pmc">PMC3195533</ArticleId><ArticleId IdType="pubmed">22013485</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathias CJ, Owens A, Iodice V, Hakim A. Dysautonomia in the Ehlers-Danlos syndromes and hypermobility spectrum disorders-with a focus on the postural tachycardia syndrome. Am J Med Genet C Semin Med Genet. (2021) 187:510&#x2013;9. doi: 10.1002/ajmg.c.31951, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31951</ArticleId><ArticleId IdType="pubmed">34766441</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Gao G, Peterson BZ, Ouyang A. TRPA1 in mast cell activation-induced long-lasting mechanical hypersensitivity of vagal afferent C-fibers in guinea pig esophagus. Am J Physiol Gastrointest Liver Physiol. (2009) 297:G34&#x2013;42. doi: 10.1152/ajpgi.00068.2009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00068.2009</ArticleId><ArticleId IdType="pubmed">19423751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, George SJ, Thompson DA, Silverman HA, Tsaava T, Tynan A, et al. . Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm. Mol Med. (2022) 28:57. doi: 10.1186/s10020-022-00483-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00483-8</ArticleId><ArticleId IdType="pmc">PMC9109205</ArticleId><ArticleId IdType="pubmed">35578169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackey E, Thelen KM, Bali V, Fardisi M, Trowbridge M, Jordan CL, et al. . Perinatal androgens organize sex differences in mast cells and attenuate anaphylaxis severity into adulthood. Proc Natl Acad Sci USA. (2020) 117:23751&#x2013;61. doi: 10.1073/pnas.1915075117, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1915075117</ArticleId><ArticleId IdType="pmc">PMC7519313</ArticleId><ArticleId IdType="pubmed">32917815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackey E, Moeser AJ. Sex differences in mast cell-associated disorders: a life span perspective. Cold Spring Harb Perspect Biol. (2022) 14:1&#x2013;14. doi: 10.1101/cshperspect.a039172, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a039172</ArticleId><ArticleId IdType="pmc">PMC9524281</ArticleId><ArticleId IdType="pubmed">35817512</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SJ, Sichlau MJ, Smith BH, Knight DRT, Chen B, Rowe PC. Improvement in chronic pelvic pain, orthostatic intolerance and interstitial cystitis symptoms after treatment of pelvic vein insufficiency. Phlebology. (2023) 39:202&#x2013;13. doi: 10.1177/02683555231219737</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02683555231219737</ArticleId><ArticleId IdType="pubmed">38050791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston CK, Padilla E, Van DT, Boone C, You S, Roberts AC, et al. . May-Thurner syndrome in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: a case series. Eur Heart J Case Rep. (2022) 6:1&#x2013;7. doi: 10.1093/ehjcr/ytac161</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytac161</ArticleId><ArticleId IdType="pmc">PMC9131024</ArticleId><ArticleId IdType="pubmed">35620060</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SJ, Smith BH, Sichlau MJ, Chen B, Knight D, Rowe PC. Nonpelvic comorbid symptoms of 45 patients with pain of pelvic venous origin, before and after treatment. Phlebology. (2024):2683555241273109. doi: 10.1177/02683555241273109</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02683555241273109</ArticleId><ArticleId IdType="pubmed">39126670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Peluso MJ, Rodgers K, Aberg JA, Patterson TF, Tamburro R, et al. . Therapeutic trials for long COVID-19: a call to action from the interventions taskforce of the RECOVER initiative. Front Immunol. (2023) 14:1129459. doi: 10.3389/fimmu.2023.1129459, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1129459</ArticleId><ArticleId IdType="pmc">PMC10034329</ArticleId><ArticleId IdType="pubmed">36969241</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. (2021) 96:2861&#x2013;78. doi: 10.1016/j.mayocp.2021.07.004, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, et al. . Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. (2023) 74:1179&#x2013;86. doi: 10.3233/WOR-220581, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A, Lacombe V, Ravaiau C, Delattre E, Ghali M, Urbanski G, et al. . The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome. J Transl Med. (2023) 21:375. doi: 10.1186/s12967-023-04229-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04229-w</ArticleId><ArticleId IdType="pmc">PMC10248991</ArticleId><ArticleId IdType="pubmed">37291581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann K, Hainzl A, Stingl M, Kurz K, Biesenbach B, Bammer C, et al. . Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome. Wien Klin Wochenschr. (2024) 136:103&#x2013;23. doi: 10.1007/s00508-024-02372-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-024-02372-y</ArticleId><ArticleId IdType="pmc">PMC11093804</ArticleId><ArticleId IdType="pubmed">38743348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadeh FH, Wilson DR, Agrawal DK. Long COVID: complications, underlying mechanisms, and treatment strategies. Arch Microbiol Immunol. (2023) 7:36&#x2013;61. PMID:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10310313</ArticleId><ArticleId IdType="pubmed">37388279</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R, Trimarco V, Mone P, Alo&#xe8; T, Capra Marzani M, Diana A, et al. . Combining L-arginine with vitamin C improves long-COVID symptoms: the LINCOLN survey. Pharmacol Res. (2022) 183:106360. doi: 10.1016/j.phrs.2022.106360, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, ibn Hadjamor H, Torjmen S, Kraiem S, Hammami R, Bahloul A, et al. . Sulodexide in the treatment of patients with long COVID 19 symptoms and endothelial dysfunction: the results of TUN-EndCOV study. Arch Cardiovasc Dis. (2022) 14:127. doi: 10.1016/j.acvdsp.2021.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvdsp.2021.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Eissa N, Al-Houqani M, Sadeq A, Ojha SK, Sasse A, Sadek B. Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder. Front Neurosci. (2018) 12:304. doi: 10.3389/fnins.2018.00304, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00304</ArticleId><ArticleId IdType="pmc">PMC5964170</ArticleId><ArticleId IdType="pubmed">29867317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton MJ, Chapman BP, Van Marwijk H. Low-dose naltrexone as a treatment for chronic fatigue syndrome. BMJ Case Rep. (2020) 13:e232502. doi: 10.1136/bcr-2019-232502</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-232502</ArticleId><ArticleId IdType="pmc">PMC6954765</ArticleId><ArticleId IdType="pubmed">31911410</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Shin KM, Do A, Bierle DM, Abu Dabrh AM, Yin Z, et al. . The safety and efficacy of low-dose naltrexone in patients with fibromyalgia: a systematic review. J Pain Res. (2023) 16:1017&#x2013;23. doi: 10.2147/JPR.S395457, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S395457</ArticleId><ArticleId IdType="pmc">PMC10039621</ArticleId><ArticleId IdType="pubmed">36974308</ArticleId></ArticleIdList></Reference><Reference><Citation>Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. (2013) 65:529&#x2013;38. doi: 10.1002/art.37734, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37734</ArticleId><ArticleId IdType="pubmed">23359310</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Kelly B, Vidal L, McHugh T, Woo J, Avramovic G, Lambert JS. Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study. Brain Behav Immun Health. (2022) 24:100485. doi: 10.1016/j.bbih.2022.100485, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100485</ArticleId><ArticleId IdType="pmc">PMC9250701</ArticleId><ArticleId IdType="pubmed">35814187</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallkamp Tidd SJ, Cantrell C, Greene BD, Wilson R. Low-dose naltrexone use in postural orthostatic tachycardia syndrome: a case series. Cureus. (2023) 15:e43426. doi: 10.7759/cureus.43426, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.43426</ArticleId><ArticleId IdType="pmc">PMC10497067</ArticleId><ArticleId IdType="pubmed">37706146</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Myers TL, Goodman B. Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment. BMJ Case Rep. (2018) 2018:bcr-2017-221405. doi: 10.1136/bcr-2017-221405, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2017-221405</ArticleId><ArticleId IdType="pmc">PMC5778345</ArticleId><ArticleId IdType="pubmed">29326369</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus NJ, Robbins L, Araki A, Gracely EJ, Theoharides TC. Effective doses of low-dose naltrexone for chronic pain - an observational study. J Pain Res. (2024) 17:1273&#x2013;84. doi: 10.2147/JPR.S451183, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S451183</ArticleId><ArticleId IdType="pmc">PMC10964028</ArticleId><ArticleId IdType="pubmed">38532991</ArticleId></ArticleIdList></Reference><Reference><Citation>Lie M, van der Giessen J, Fuhler GM, de Lima A, Peppelenbosch MP, van der Ent C, et al. . Low dose naltrexone for induction of remission in inflammatory bowel disease patients. J Transl Med. (2018) 16:55. doi: 10.1186/s12967-018-1427-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1427-5</ArticleId><ArticleId IdType="pmc">PMC5845217</ArticleId><ArticleId IdType="pubmed">29523156</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasricha PJ, McKnight M, Villatoro L, Barahona G, Brinker J, Hui K, et al. . A syndrome of joint hypermobility, autonomic dysfunction, gastrointestinal dysfunction and autoimmune markers (JAG-A): clinical associations and response to intravenous immunoglobulin therapy. medRxiv. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11524627</ArticleId><ArticleId IdType="pubmed">38912927</ArticleId></ArticleIdList></Reference><Reference><Citation>Achleitner M, Steenblock C, D&#xe4;nhardt J, Jarzebska N, Kardashi R, Kanczkowski W, et al. . Clinical improvement of long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol Psychiatry. (2023) 28:2872&#x2013;7. doi: 10.1038/s41380-023-02084-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02084-1</ArticleId><ArticleId IdType="pmc">PMC10152027</ArticleId><ArticleId IdType="pubmed">37131073</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein E, Heindrich C, Wittke K, Kedor CA-O, Kim LA-O, Freitag HA-O, et al. . Observational study of repeat immunoadsorption (RIA) in post-COVID ME/CFS patients with elevated &#xdf;2-adrenergic receptor autoantibodies-an interim report. J Clin Med. (2023) 12:6428. doi: 10.3390/jcm12196428</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12196428</ArticleId><ArticleId IdType="pmc">PMC10573450</ArticleId><ArticleId IdType="pubmed">37835071</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy MW. Intravenous immunoglobulin as a potential treatment for long COVID. Expert Opin Biol Ther. (2023) 23:1211&#x2013;7. doi: 10.1080/14712598.2023.2296569</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2023.2296569</ArticleId><ArticleId IdType="pubmed">38100573</ArticleId></ArticleIdList></Reference><Reference><Citation>Pre&#xdf;ler H, Machule ML, Ufer F, B&#xfc;nger I, Li LY, Buchholz E, et al. . IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS). Trials. (2024) 25:172. doi: 10.1186/s13063-024-07982-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-024-07982-5</ArticleId><ArticleId IdType="pmc">PMC10919018</ArticleId><ArticleId IdType="pubmed">38454468</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel JM, Pollack B, Spier E, McCorkell L, Jaudon TW, Fitzgerald M, et al. . Designing and optimizing clinical trials for long COVID. Life Sci. (2024) 355:122970. doi: 10.1016/j.lfs.2024.122970, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2024.122970</ArticleId><ArticleId IdType="pubmed">39142505</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeoch CLB, Steinberg RS, Bortfeld KS, Almuwaqqat Z, Rheudasil JM, Bhatia NK, et al. . Radiofrequency venous ablation for symptomatic relief in postural orthostatic tachycardia syndrome: a case series. Eur Heart J Case Rep. (2024) 8:ytae029. doi: 10.1093/ehjcr/ytae029</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytae029</ArticleId><ArticleId IdType="pmc">PMC10849078</ArticleId><ArticleId IdType="pubmed">38328599</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC . New ICD-19-CM code for post-COVID conditions, following the 2019 novel coronavirus (COVID-19) (2021). Available at: https://www.cdc.gov/nchs/data/icd/announcement-new-icd-code-for-post-covid-condition-april-2022-final.pdf (Accessed August 18, 2024).</Citation></Reference><Reference><Citation>CDC . Technical updates. CDC archive. (2021). Available at: https://archive.cdc.gov/www_cdc_gov/nssp/news/2021/03-march/technical-updates.html (Accessed August 18, 2024).</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. (2009) 42:377&#x2013;81. doi: 10.1016/j.jbi.2008.08.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. . The REDCap consortium: building an international community of software platform partners. J Biomed Inform. (2019) 95:103208. doi: 10.1016/j.jbi.2019.103208, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>